Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: A Study of VG712 in Patients With Mycosis Fungoides [Phase 2]

View source ↗

Summary

Phase 2 study update for VG712 in mycosis fungoides; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VG712

Snippet

Sponsor: Virogen Biotechnology Inc. | Conditions: Mycosis Fungoides | Phase 2 | Status: NOT_YET_RECRUITING